Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 159

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

315	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/31/2014 10:15:24 AM
314	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/31/2014 9:47:55 AM
313	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/31/2014 9:38:08 AM
312	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/31/2014 9:02:53 AM
311	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/31/2014 8:48:16 AM
310	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/30/2014 3:46:34 PM
309	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/30/2014 3:22:19 PM
308	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/30/2014 3:01:59 PM
307	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/30/2014 2:29:34 PM
306	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/30/2014 1:52:13 PM
305	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/30/2014 1:16:44 PM
304	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/30/2014 12:34:49 PM
303	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/30/2014 12:16:25 PM
302	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/30/2014 11:19:33 AM
301	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/30/2014 10:57:48 AM
300	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/30/2014 10:43:17 AM
299	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/30/2014 10:07:21 AM
298	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/30/2014 9:40:14 AM
297	NVLX news:	stocklegend	01/30/2014 9:23:35 AM
296	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/30/2014 8:47:34 AM
295	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/29/2014 3:58:37 PM
294	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/29/2014 2:11:23 PM
293	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/29/2014 2:01:12 PM
292	$NVLX Nuvilex Accelerates Development of	stocklegend	01/29/2014 1:46:28 PM
291	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/29/2014 1:13:59 PM
290	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/29/2014 12:51:13 PM
289	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/29/2014 11:56:37 AM
288	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/29/2014 11:36:42 AM
287	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/29/2014 10:37:17 AM
286	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/29/2014 10:01:23 AM
285	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/29/2014 9:37:53 AM
284	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/29/2014 9:14:26 AM
283	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/29/2014 8:46:56 AM
282	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/28/2014 3:39:00 PM
281	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/28/2014 3:20:27 PM
280	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/28/2014 2:22:54 PM
279	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	01/28/2014 1:38:34 PM
278	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	01/28/2014 12:15:23 PM
277	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/28/2014 11:36:48 AM
276	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/28/2014 11:05:41 AM
275	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/28/2014 10:19:28 AM
274	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/28/2014 9:58:22 AM
273	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/28/2014 9:32:56 AM
272	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 9:17:32 AM
271	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 8:49:13 AM
270	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/27/2014 3:42:16 PM
269	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/27/2014 3:20:19 PM
268	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/27/2014 3:06:46 PM
267	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/27/2014 2:40:30 PM
266	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/27/2014 2:18:40 PM

Newer

Older

Recent Articles

• High Arctic Overseas Reports Q3 2024 Financial Highlights
• Grab Unmissable Offers Before Monport's Black Friday Ends
• Canadian Spirit Resources Highlights First Quarter Financials
• Innovation at the Expo: Where Sci-Fi Meets Reality
• Rakovina Therapeutics Reports Q3 Financial Progress and Innovations
• Innovative Transportation Concepts at the China Supply Chain Expo
• Exploring Hotpot Culture at the China International Supply Chain Expo
• CBC Group and Mubadala Form NeuroGen Pharma for Growth
• GVD Markets Launches Global Expansion with Unique Trading Solutions
• CBC Group and Mubadala Form NeuroGen Pharma in China Deal
• Hampton Financial Corporation Distributes Stock Options for Growth
• Tice Family Takes Stand for Journalist in Press Conference
• ProMortgage Expands Team With Four Experienced Professionals
• Unlock Seamless Communication with iFLYTEK's Smart Translator
• Investor Alert: Acadia Healthcare Class Action Insights
• O2Gold Expands Acquisition Plans for Quebec Aur Property
• Brazil Potash Celebrates Successful Initial Public Offering
• ISS Endorses Director Nominees for Carver Bancorp, Inc.
• Deadline for Shareholder Distribution Approval Announced by LWP
• Axis Auto Finance Inc. Annual Meeting Voting Results Overview
• Fluent, Inc. Secures $5.75 Million Through Direct Offerings
• The Future of Silicon Photonics: Trends and Insights for Growth
• Expansion of Managed Services Market in Saudi Arabia Forecasted
• Cloud ERP Market Growth Driven by AI and Digital Transformation
• Exploring the Growth of the Titanium Market and AI's Impact
• Syntheia: Transforming Customer Engagement with AI Solutions
• Photonics Market Growth Forecast: Major Innovations Ahead
• Strategic Management Transition at Premier American Uranium
• Financial Overview of Patagonia Gold for Q3 2024
• First Savings Financial Group Declares Quarterly Dividend for 2024
• Anoto Group Introduces Its Latest Prospectus for Investment Opportunities
• Inovalis REIT Moves Forward with €18.2 Million Property Sale
• State Street Leadership Prepares for Goldman Sachs Conference
• XTM Inc. Celebrates Impressive Q3 2024 Performance with Growth
• Investors Excited for Lightspeed's Upcoming Conference Participation
• Emerging Trends in Cannabis Testing Market Boost Growth
• Halmont Properties' Strong Q3 Performance and Future Outlook
• Brookfield Infrastructure Announces Major Subordinated Note Deal
• Investigation Launched Against Customers Bancorp, Inc. Amid Losses
• Red White & Bloom Achieves Major Growth in Q3 Financials
• Cue Biopharma Welcomes New Chief Development Officer
• WeRide Inc. Launches GXR Robotaxi Platform and Strategic Growth
• Aspen Insurance's Preference Shares Redemption Announcement
• Chemours Successfully Reprices U.S. Dollar Term Loan Facility
• Understanding the Walgreens Boots Alliance Shareholder Settlement
• Innovative Mobile MRI Scanner Revolutionizes Healthcare Imaging
• Amgen Leadership Set to Speak at Key Healthcare Conference
• JB Perrette to Share Insights at Upcoming TMT Summit Event
• Neuberger Berman Real Estate Fund Declares Monthly Dividend
• Neuberger Berman Energy Fund Declares Monthly Cash Distribution